Pharmaceuticals firm Ascendis Health’s offer of 80c a share to buy out shareholders and delist the firm is fair, even if leaked and disputed information is taken into account.
That is according to a new report by financial advisory firm BDO, a copy of which is in Business Day’s possession. The report was commissioned by the Ascendis board after ousted chair Harry Smit published a presentation on X (formerly Twitter), which revealed that insiders believe the firm was worth far more than the offer to minorities...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.